Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
IMpassion130: updated overall survival (OS) from a global, randomized, double-blind, placebo-controlled, Phase III study of atezolizumab (atezo) + nab-paclitaxel (nP) in previously untreated locally advanced or metastatic triple-negative breast cancer (mTNBC)
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Peter Schmid, Sylvia Adams, Hope S. Rugo, et. al. Abstract: 1003 Clinical Trial Registry Number: NCT02425891 ...
Adding Ribociclib to First-Line Endocrine Therapy Significantly Improves Survival for Pre-Menopausal Women with Advanced Breast Cancer
18 septembra, 2020 8:00 pm Leave your thoughtsJune 1, 2019 Adding Ribociclib to First-Line Endocrine Therapy Significantly Improves Survival for Pre-Menopausal Women with Advanced Breast Cancer...
VÝROČNÁ KONFERENCIA ASCO® 2019 Vybrané referáty – karcinóm prsníka
18 septembra, 2020 8:00 pm Leave your thoughtsTohtoročná výročná konferencia ASCO® nepriniesla na poli liečby a diagnostiky karcinómu prsníka žiadnu prelomovú správu. Napriek tomu sa dá toto významné...
RATIFY: PROGNOSTIC IMPACT OF FLT3 TYROSINE KINASE DOMAIN (TKD) AND NPM1 MUTATION STATUS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) TREATED WITH MIDOSTAURIN + STANDARD CHEMOTHERAPY
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): Maria Teresa Voso, Richard A. Larson, Thomas Prior, et. al. EHA Library. Voso M. Jun 14, 2019; 266056; PF256...
RESULTS OF ASTRAL-1 STUDY, A PHASE III RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN-AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): Pierre Fenaux, Marco Gobbi, Patricia L. Kropf, et. al. EHA Library. Fenaux P. Jun 15, 2019; 267462; S879 ...
A PHASE II STUDY OF SELINEXOR PLUS CYTARABINE AND IDARUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): Walter Fiedler, Joerg Chromik, Stefanie Amberg, et. al.: EHA Library. Fiedler W. Jun 15, 2019; 267463; S880 Abstract:...
Pozoruhodnosti o AML na EHA© 2019
15 septembra, 2020 7:11 pm Leave your thoughts24. kongres Európskej hematologickej asociácie (EHA) sa konal tento rok 13. – 16. júna v holandskom Amsterdame. Kongres navštívilo rekordných 12 000...
RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): Anna Sicuranza, Corrado Zuanelli Brambilla, Ilaria Ferrigno, et. al. EHA Library. Sicuranza A. Jun 14, 2019; 266220; PF420 ...
DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): David M. Ross, Tamas Masszi, María Teresa, et. al. EHA Library. Ross D. Jun 14, 2019; 266209; PF409 ...
TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING FIRST-LINE DASATINIB, 1ST DADI/IMIDAS4
15 septembra, 2020 7:11 pm Leave your thoughtsAuthor(s): Kazunori Murai, Shinya Kimura, Jun Imagawa, et. al. EHA Library. MURAI K. Jun 14, 2019; 266207; PF407 Abstract:...